The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?

Objective: Recent studies have shown that the presence of systemic inflammation and platelet status correlate with poor survival in various cancers. The aim of this study was to evaluate the prognostic value of the preoperative platelet–lymphocyte ratio (PLR) and the neutrophil–lymphocyte ratio (NLR...

Full description

Bibliographic Details
Main Authors: Shan Chen, Junbing Guo, Chongjin Feng, Zunfu Ke, Leihui Chen, Yunping Pan
Format: Article
Language:English
Published: SAGE Publishing 2016-05-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758834016638019
id doaj-db9fbc39cb5d4c4f8db1b8dd13c6aa21
record_format Article
spelling doaj-db9fbc39cb5d4c4f8db1b8dd13c6aa212020-11-25T02:58:19ZengSAGE PublishingTherapeutic Advances in Medical Oncology1758-83401758-83592016-05-01810.1177/1758834016638019The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?Shan ChenJunbing GuoChongjin FengZunfu KeLeihui ChenYunping PanObjective: Recent studies have shown that the presence of systemic inflammation and platelet status correlate with poor survival in various cancers. The aim of this study was to evaluate the prognostic value of the preoperative platelet–lymphocyte ratio (PLR) and the neutrophil–lymphocyte ratio (NLR) in patients with oral squamous cell carcinoma (OSCC) undergoing surgery. Methods: In this study, 306 patients with OSCC who had surgery were enrolled. The optimal cutoff value of PLR and NLR was determined by receiver operating characteristic (ROC) curve analysis. The prognostic significance of both markers was determined by uni- and multivariate analysis. Results: The results showed that high NLR and PLR were classified using a cutoff value of 2.7 and 135, respectively, based on ROC curve analysis. Only PLR was associated with decreased disease-free survival [hazard ratio (HR) = 2.237; 95% confidence interval (CI): 1.401–3.571; p = 0.001] and overall survival [HR = 2.022; 95% CI: 1.266–3.228; p = 0.003] by both uni- and multivariate analysis. Conclusion: The preoperative PLR is superior to NLR as an independent indicator in predicting disease-free survival and overall survival in patients who undergo oral cancer resection for OSCC.https://doi.org/10.1177/1758834016638019
collection DOAJ
language English
format Article
sources DOAJ
author Shan Chen
Junbing Guo
Chongjin Feng
Zunfu Ke
Leihui Chen
Yunping Pan
spellingShingle Shan Chen
Junbing Guo
Chongjin Feng
Zunfu Ke
Leihui Chen
Yunping Pan
The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
Therapeutic Advances in Medical Oncology
author_facet Shan Chen
Junbing Guo
Chongjin Feng
Zunfu Ke
Leihui Chen
Yunping Pan
author_sort Shan Chen
title The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
title_short The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
title_full The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
title_fullStr The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
title_full_unstemmed The preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
title_sort preoperative platelet–lymphocyte ratio neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
publisher SAGE Publishing
series Therapeutic Advances in Medical Oncology
issn 1758-8340
1758-8359
publishDate 2016-05-01
description Objective: Recent studies have shown that the presence of systemic inflammation and platelet status correlate with poor survival in various cancers. The aim of this study was to evaluate the prognostic value of the preoperative platelet–lymphocyte ratio (PLR) and the neutrophil–lymphocyte ratio (NLR) in patients with oral squamous cell carcinoma (OSCC) undergoing surgery. Methods: In this study, 306 patients with OSCC who had surgery were enrolled. The optimal cutoff value of PLR and NLR was determined by receiver operating characteristic (ROC) curve analysis. The prognostic significance of both markers was determined by uni- and multivariate analysis. Results: The results showed that high NLR and PLR were classified using a cutoff value of 2.7 and 135, respectively, based on ROC curve analysis. Only PLR was associated with decreased disease-free survival [hazard ratio (HR) = 2.237; 95% confidence interval (CI): 1.401–3.571; p = 0.001] and overall survival [HR = 2.022; 95% CI: 1.266–3.228; p = 0.003] by both uni- and multivariate analysis. Conclusion: The preoperative PLR is superior to NLR as an independent indicator in predicting disease-free survival and overall survival in patients who undergo oral cancer resection for OSCC.
url https://doi.org/10.1177/1758834016638019
work_keys_str_mv AT shanchen thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT junbingguo thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT chongjinfeng thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT zunfuke thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT leihuichen thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT yunpingpan thepreoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT shanchen preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT junbingguo preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT chongjinfeng preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT zunfuke preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT leihuichen preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
AT yunpingpan preoperativeplateletlymphocyterationeutrophillymphocyteratiowhichisbetterasaprognosticfactorinoralsquamouscellcarcinoma
_version_ 1724707105473036288